As glycolytic activity is elevated in PA-treated and IFN-γ-exposed mice with RV infection, we tested if 2-DG, an inhibitor of glucose conversion to glucose-6-phosphate via inhibition of hexokinase, attenuated viral infection. Here, IFNG is linked to viral infectious disease.